None
Quote | BridgeBio Pharma Inc. (NYSE:BBIO)
Last: | $ |
---|---|
Change Percent: | -0.55% |
Open: | $35.05 |
Close: | $34.65 |
High: | $35.07 |
Low: | $33.77 |
Volume: | 249,717 |
Last Trade Date Time: | 02/12/2020 04:42:27 pm |
News | BridgeBio Pharma Inc. (NYSE:BBIO)
2024-04-09 22:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- In this exploratory substudy, treatment with acoramidis was associated with possible cardiac structural and functional improvement compared with placebo, with potential cardiac amyloid regression - The data demonstrate that targeting near-complete transthyretin (TTR) stabilization wit...
Message Board Posts | BridgeBio Pharma Inc. (NYSE:BBIO)
Subject | By | Source | When |
---|---|---|---|
Offering comign | Pt3 | investorshub | 03/06/2023 4:47:20 PM |
BridgeBio Announces Positive Phase 2 Cohort 5 Results | 02opida | investorshub | 03/06/2023 4:21:16 PM |
BridgeBio Announces Positive Phase 2 Cohort 5 Results | subslover | investorshub | 03/06/2023 1:34:59 PM |
Recent Trades - Last 10 of 1063 | 02opida | investorshub | 12/08/2022 4:21:10 PM |
volume will start to pickup | 02opida | investorshub | 08/09/2022 6:09:28 PM |
News, Short Squeeze, Breakout and More Instantly...
BridgeBio Pharma Inc. Company Name:
BBIO Stock Symbol:
NYSE Market:
2024-04-09 22:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- In this exploratory substudy, treatment with acoramidis was associated with possible cardiac structural and functional improvement compared with placebo, with potential cardiac amyloid regression - The data demonstrate that targeting near-complete transthyretin (TTR) stabilization wit...
2024-03-20 22:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...